The impact of the hypermethylated NKX6-2 gene has been reported in bladder cancer, renal cancer, and lung adenocarcinoma, and this is consistent with our results in colorectal cancer specimens. The gene discussed is NKX6-2; the disease is urinary bladder cancer.